Jubilant Pharmova Statistics

Total Valuation

NSE:JUBLPHARMA has a market cap or net worth of INR 167.24 billion. The enterprise value is 183.50 billion.

Market Cap	167.24B
Enterprise Value	183.50B

Important Dates

The last earnings date was Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	158.35M
Shares Outstanding	n/a
Shares Change (YoY)	+0.33%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	63.37M

Valuation Ratios

The trailing PE ratio is 36.34 and the forward PE ratio is 27.44.

PE Ratio	36.34
Forward PE	27.44
PS Ratio	2.26
PB Ratio	2.68
P/TBV Ratio	6.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	39.87
EV / Sales	2.48
EV / EBITDA	14.94
EV / EBIT	21.97
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.44
Debt / EBITDA	2.22
Debt / FCF	n/a
Interest Coverage	3.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.79%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	13.71M
Profits Per Employee	852,380
Employee Count	5,399
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:JUBLPHARMA has paid 1.78 billion in taxes.

Income Tax	1.78B
Effective Tax Rate	28.07%

Stock Price Statistics

The stock price has increased by +24.03% in the last 52 weeks. The beta is 0.70, so NSE:JUBLPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+24.03%
50-Day Moving Average	1,156.93
200-Day Moving Average	1,050.68
Relative Strength Index (RSI)	31.80
Average Volume (20 Days)	364,729

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:JUBLPHARMA had revenue of INR 74.04 billion and earned 4.60 billion in profits. Earnings per share was 28.97.

Revenue	74.04B
Gross Profit	50.30B
Operating Income	8.36B
Pretax Income	6.35B
Net Income	4.60B
EBITDA	12.29B
EBIT	8.36B
Earnings Per Share (EPS)	28.97

Full Income Statement

Balance Sheet

The company has 10.89 billion in cash and 27.31 billion in debt, giving a net cash position of -16.42 billion.

Cash & Cash Equivalents	10.89B
Total Debt	27.31B
Net Cash	-16.42B
Net Cash Per Share	n/a
Equity (Book Value)	62.39B
Book Value Per Share	395.41
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.94%, with operating and profit margins of 11.29% and 6.22%.

Gross Margin	67.94%
Operating Margin	11.29%
Pretax Margin	8.58%
Profit Margin	6.22%
EBITDA Margin	16.60%
EBIT Margin	11.29%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.47%.

Dividend Per Share	5.00
Dividend Yield	0.47%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.33%
Shareholder Yield	0.14%
Earnings Yield	2.75%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 17, 2006. It was a forward split with a ratio of 5.

Last Split Date	Mar 17, 2006
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1